Is NAD+ FDA approved?
No. This profile records NAD+ as not FDA approved and for research use only.
MORE CONTEXT ›
Review the regulatory and source details on this page for the current context.
THE ENERGIZER
Nicotinamide Adenine Dinucleotide
NAD+ is a vital coenzyme that powers energy production in your mitochondria and switches on sirtuins for repair and longevity. Levels drop with age, so boosting it, often through precursors like NMN or NR, helps support metabolism, DNA repair, and cellular health.
Not FDA approved · research use only
Reviewed by our clinical team
4 research sources
Jul 15, 2026
Dose and schedule recommendations shown below come from The Peptide App Clinical Team. Research links are provided so readers can inspect the supporting evidence directly. Review the sources.
No. This profile records NAD+ as not FDA approved and for research use only.
Review the regulatory and source details on this page for the current context.
Dose: 25 mg subcutaneously twice weekly; or IV infusion 250-500mg.
Schedule: twice_weekly. Cycle: 8 weeks on, 8 weeks off (for injections). This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.
This guide links to 4 curated or current research sources.
Open the research section to inspect the source titles, publication details, study types, and available abstracts directly.
Essential coenzyme for cellular energy production
NAD+ (nicotinamide adenine dinucleotide) is the electron shuttle at the center of how your cells turn food into usable energy. In glycolysis, the citric acid cycle, and oxidative phosphorylation, NAD+ picks up electrons to become NADH, then hands them off to the mitochondrial electron transport chain that ultimately produces ATP. Without enough NAD+ in its oxidized form, these reactions stall, so cellular NAD+ levels effectively set the ceiling on how much energy a cell can generate. This role is well-established biochemistry, though the extent to which raising NAD+ improves human energy or performance is still an active area of study.
What the research shows
NAD+ in Cellular Function and Aging Reviews NAD+ as a central redox coenzyme whose availability shapes cellular metabolism and energy output. NAD+ Metabolism and Aging - Sinclair Lab Review Describes how NAD+ metabolism supports mitochondrial function and tends to decline with age.Activates longevity genes that regulate aging
Sirtuins are a family of enzymes that can only do their job when NAD+ is present, because they consume NAD+ each time they act. They chemically edit proteins and DNA-packaging histones in ways linked to stress resistance, metabolism, and cellular repair, which is why they are often called "longevity" regulators. The idea is that as NAD+ falls with age, sirtuin activity drops with it, so restoring NAD+ may help keep these pathways running. Most of this work comes from cell and animal models, and the human longevity payoff remains unproven.
Fuels PARP enzymes that fix DNA damage
PARP enzymes detect breaks and damage in DNA and use NAD+ as their fuel to flag and coordinate repair. Every time DNA is damaged, PARPs draw down the cellular NAD+ pool, which means heavy or chronic damage can compete with other NAD+-dependent processes like sirtuins and energy production. Keeping NAD+ levels adequate helps ensure this repair machinery has the substrate it needs to work. This is grounded in established cell biology, but evidence that supplementing NAD+ meaningfully improves DNA repair in people is still early.
What the research shows
NAD+ Metabolism and Aging - Sinclair Lab Review Explains PARP enzymes' reliance on NAD+ for DNA repair and how that competes for the shared NAD+ pool. NAD+ in Cellular Function and Aging Covers NAD+ as a shared substrate consumed by DNA-repair enzymes across cellular functions.Supports brain health and cognitive function
Neurons are especially energy-hungry, so they depend heavily on NAD+ both to power their mitochondria and to run the repair and stress-response enzymes that keep cells healthy. The thinking is that as NAD+ declines with age, brain cells become more vulnerable, and maintaining NAD+ may help preserve mitochondrial function and cellular resilience in the nervous system. This is a plausible extension of NAD+'s core roles rather than a proven cognitive benefit. The neuroprotection evidence is largely preclinical, and effects on human brain health and cognition have not been established.
NAD+ is short for nicotinamide adenine dinucleotide, a coenzyme rather than a peptide. It is a small molecule the body builds from precursors related to vitamin B3, and it sits inside every cell as one of the most fundamental helpers in metabolism. It was first described in the early 1900s by researchers studying how yeast ferments sugar, and its role as an electron carrier was worked out over the following decades. The body keeps it in constant circulation because it is consumed and regenerated many times a day as cells make energy. More recent interest traces to the discovery that a family of enzymes called sirtuins depend on NAD+ to function, which tied the coenzyme to research on aging and repair.
Most people look into NAD+ for energy, mental clarity, and a general sense of feeling less worn down, since cellular NAD+ levels tend to fall with age. It has become a fixture at med spas and IV lounges, often marketed alongside injectable peptides as part of a broader wellness or longevity push. Some users treat it as a foundation and layer other compounds on top, with the loose framing that NAD+ recharges the cell while peptides target more specific goals. Lesser known interest comes from research on brain metabolism, recovery, and the enzymes involved in DNA repair. A lot of the enthusiasm outpaces the evidence, and reported benefits vary a great deal from person to person.
NAD+ works mainly as an electron shuttle inside the process that turns food into usable energy. It exists in two forms, an oxidized form written as NAD+ and a reduced form written as NADH, and it flips between them as it carries electrons through the Krebs cycle and into the electron transport chain, where the large majority of a cell’s ATP is produced. Beyond energy, NAD+ is a required fuel for sirtuins and for PARP enzymes involved in DNA repair, which is why it gets linked to aging and cellular maintenance. What makes it unusual is that it is not a signaling drug that switches one pathway on or off, but a shared currency that hundreds of reactions draw from at once. That broad role is also why its effects are hard to pin down, since raising a level in the blood does not guarantee more of it reaches the tissues that need it.
NAD+ is offered in several forms, and the choice shapes how much actually reaches cells. Intravenous drips deliver it directly into the bloodstream and are common at clinics and IV lounges, while subcutaneous injections are used for a slower, at-home style of dosing. Oral capsules of NAD+ itself are considered poorly absorbed, so many people instead take precursors such as NMN or NR by mouth and let the body convert them into NAD+. A recurring theme in the discussion is that a rise in blood levels may not translate cleanly to the brain or muscle, which is one reason experiences differ so widely. Cadence, form, and dose are all places where reported practice varies; nothing here is settled guidance.
The basic biochemistry of NAD+ is well established, and the observation that levels decline with age is broadly accepted. The weaker link is between raising NAD+ and the specific benefits people are chasing, such as more energy, sharper focus, or slower aging. Much of the supporting work comes from cell and animal studies, and human trials of precursors like NMN and NR have been small and mixed, often showing that blood markers move without clearly proving how a person feels or functions changes. There is active research into NAD+ and brain metabolism, including work framing conditions like Alzheimer’s around impaired cellular energy rather than plaques alone, but this is early and not settled. NAD+ is real and important biology wrapped in marketing that runs ahead of the clinical proof.
NAD+ itself is not an approved drug, and it circulates through wellness clinics, compounding pharmacies, and supplement channels rather than as a standard prescription therapy. Its precursors have their own shifting status, and NMN in particular has been a moving target, having gone through periods of FDA enforcement uncertainty over whether it can be sold as a dietary supplement, while NR has generally remained available as one. People also encounter the coenzyme under its full name, nicotinamide adenine dinucleotide, and the precursor side under names like NMN, NR, nicotinamide, and niacin.
The live research feed did not return papers for this page. The curated references below remain available for crawlable source context.